100 related articles for article (PubMed ID: 28903344)
41. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis.
Knight JC; Renwick PJ; Dal Cin P; Van den Berghe H; Fletcher CD
Cancer Res; 1995 Jan; 55(1):24-7. PubMed ID: 7805034
[TBL] [Abstract][Full Text] [Related]
42. High-fidelity of non-small cell lung cancer xenograft models derived from bronchoscopy-guided biopsies.
Fu S; Zhao J; Bai H; Duan J; Wang Z; An T; Wang J
Thorac Cancer; 2016 Jan; 7(1):100-10. PubMed ID: 26813258
[TBL] [Abstract][Full Text] [Related]
43. Validity of patient-derived xenograft mouse models for lung cancer based on exome sequencing data.
Kim J; Rhee H; Kim J; Lee S
Genomics Inform; 2020 Mar; 18(1):e3. PubMed ID: 32224836
[TBL] [Abstract][Full Text] [Related]
44. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.
Dei Tos AP; Piccinin S; Doglioni C; Vukosavljevic T; Mentzel T; Boiocchi M; Fletcher CD
Am J Pathol; 1997 Dec; 151(6):1531-9. PubMed ID: 9403703
[TBL] [Abstract][Full Text] [Related]
45. Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.
Germano G; Frapolli R; Simone M; Tavecchio M; Erba E; Pesce S; Pasqualini F; Grosso F; Sanfilippo R; Casali PG; Gronchi A; Virdis E; Tarantino E; Pilotti S; Greco A; Nebuloni M; Galmarini CM; Tercero JC; Mantovani A; D'Incalci M; Allavena P
Cancer Res; 2010 Mar; 70(6):2235-44. PubMed ID: 20215499
[TBL] [Abstract][Full Text] [Related]
46. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
[TBL] [Abstract][Full Text] [Related]
47. Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.
de Vreeze RS; de Jong D; Koops W; Nederlof PM; Ariaens A; Haas RL; van Coevorden F
Int J Cancer; 2011 Feb; 128(4):778-86. PubMed ID: 20473880
[TBL] [Abstract][Full Text] [Related]
48. Metastatic patterns of myxoid/round cell liposarcoma: a review of a 25-year experience.
Asano N; Susa M; Hosaka S; Nakayama R; Kobayashi E; Takeuchi K; Horiuchi K; Suzuki Y; Anazawa U; Mukai M; Toyama Y; Yabe H; Morioka H
Sarcoma; 2012; 2012():345161. PubMed ID: 22550416
[TBL] [Abstract][Full Text] [Related]
49. Establishing and Maintaining an Extensive Library of Patient-Derived Xenograft Models.
Mattar M; McCarthy CR; Kulick AR; Qeriqi B; Guzman S; de Stanchina E
Front Oncol; 2018; 8():19. PubMed ID: 29515970
[TBL] [Abstract][Full Text] [Related]
50. The Essential Factors of Establishing Patient-derived Tumor Model.
Chen C; Lin W; Huang Y; Chen X; Wang H; Teng L
J Cancer; 2021; 12(1):28-37. PubMed ID: 33391400
[TBL] [Abstract][Full Text] [Related]
51. A risk assessment of a common drug using xenograft model.
Kodama M; Kurokawa J
Ann Transl Med; 2017 Feb; 5(4):88. PubMed ID: 28275633
[No Abstract] [Full Text] [Related]
52. Gut microbiota mediates the protective role of Lactobacillus plantarum in ameliorating deoxynivalenol-induced apoptosis and intestinal inflammation of broiler chickens.
Yang X; Liang S; Guo F; Ren Z; Yang X; Long F
Poult Sci; 2020 May; 99(5):2395-2406. PubMed ID: 32359574
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma.
Wang ZM; Zhang SL; Yang H; Zhuang RY; Guo X; Tong HX; Zhang Y; Lu WQ; Zhou YH
Cancer Med; 2020 May; 9(10):3344-3352. PubMed ID: 32181596
[TBL] [Abstract][Full Text] [Related]
54. Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical Treatment.
Yang L; Chen S; Luo P; Yan W; Wang C
J Cancer; 2020; 11(1):100-107. PubMed ID: 31892977
[TBL] [Abstract][Full Text] [Related]
55. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
[TBL] [Abstract][Full Text] [Related]
56. Establishing a patient-derived xenograft model of human myxoid and round-cell liposarcoma.
Qi Y; Hu Y; Yang H; Zhuang R; Hou Y; Tong H; Feng Y; Huang Y; Jiang Q; Ji Q; Gu Q; Zhang Z; Tang X; Lu W; Zhou Y
Oncotarget; 2017 Aug; 8(33):54320-54330. PubMed ID: 28903344
[TBL] [Abstract][Full Text] [Related]
57. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
de Graaff MA; Yu JS; Beird HC; Ingram DR; Nguyen T; Juehui Liu J; Bolshakov S; Szuhai K; Åman P; Torres KE; Lev D; Nielsen TO; Bovée JV; Lazar AJ; Somaiah N
Lab Invest; 2016 Aug; 96(8):885-94. PubMed ID: 27270875
[TBL] [Abstract][Full Text] [Related]
58. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Bode-Lesniewska B; Frigerio S; Exner U; Abdou MT; Moch H; Zimmermann DR
Genes Chromosomes Cancer; 2007 Nov; 46(11):961-71. PubMed ID: 17647282
[TBL] [Abstract][Full Text] [Related]
59. A Patient with Myxoid/Round Cell Liposarcoma (MRCL) Involving the Well-known Translocation t(12;22): A Case Report with the Cytogenomic Landscape of this Rearrangement.
Tirado CA; Su W; Chia V; Zaki M; Tang R; Eastwood K; Guardiola MT; Rao A
J Assoc Genet Technol; 2022; 48(2):68-75. PubMed ID: 35660675
[TBL] [Abstract][Full Text] [Related]
60. Myxoid liposarcoma and the mammalian target of rapamycin pathway.
Sanfilippo R; Dei Tos AP; Casali PG
Curr Opin Oncol; 2013 Jul; 25(4):379-83. PubMed ID: 23673410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
